Lateral Epicondylitis (tennis Elbow) Market Bwc20065

Global Lateral Epicondylitis (Tennis Elbow) Market by Treatment Type (Corticosteroid Injections, Surgery, Therapy (Shock Wave Therapy & Physical Therapy), Painkillers and NSAIDS, Equipment's and Other Products), By End-User (Hospital/Clinic and Pharmacy/Drug Stores), By Region (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2017-2027

  • Published Date: May 2020
  • Report ID: BWC20065
  • Available Format: PDF
  • Page: 179

Report Overview

Global Lateral Epicondylitis (Tennis Elbow) Market- Industry Trends & Forecast Report 2027

The global lateral epicondylitis (tennis elbow) market has reached USD 9,159.73 million in 2020. It is further projected to reach USD 10,734.53 million by 2027, at a CAGR of 2.30% during the forecast period (2021-2027). The increasing cases of lateral epicondylitis, along with the increase in the population of age group between 35-60 years and the launch of cost-effective treatment options are the key drivers for market growth.

Companies in the lateral epicondylitis market are increasingly investing in R&D for the development of improved and innovative treatment process technologies, which in turn is driving the market growth. At the same time, domestic organizations and hospitals are seeking guidance from international bodies for the diagnosis and treatment of the condition, which is greatly impacting the global market. The tennis elbow market is also expected to expand due to the launch of new products that facilitate the successful treatment of lateral epicondylitis (tennis elbow).Sportspersons are always at an increased risk of lateral epicondylitis as they have to perform the same task repetitively. The occurrence of lateral epicondylitis also depends on the age of the person. It is more common in people between the age group 35 and 45 as they are more vulnerable to elbow injuries.

Source: BlueWeave Consulting

Global Lateral Epicondylitis (Tennis Elbow) market overview:

Lateral epicondylitis or tennis elbow is a painful condition, that arises when tendons are overloaded. This overload is usually caused by repetitive arm movements that place an undue amount of pressure on the arm. Tennis elbow is a kind of tendinitis that causes tendon swelling and is diagnosed through a medical examination. If left untreated, it can become debilitating and may also require surgery. In the case of a tennis elbow injury, the pain occurs where tendons of the forearm muscle attach to the bony bump. Pain can also spread from elbow to forearm and wrist. When the affected arm is moved against resistance, it may have severe consequences. Diagnosis of lateral epicondylitis is performed via medical imaging tests such as X-ray, an MRI, or electromyography (EMG).Men and women between the ages of 35 and 60 years are most susceptible to this condition.

Global Lateral Epicondylitis (Tennis Elbow) market forecast and Trends

Growth Drivers 

Increasing Cases of Lateral Epicondylitis and Sports-Related Injuries

An increasing population of age group between 35-60, use of improper equipment by athletes, and strenuous activities of the armature some of the major factors responsible for lateral epicondylitis (tennis elbow). Additionally, populations at risk also involve painters, butchers, plumbers, and carpenters. In younger people, a piece of cartilage or bone in the joints may loosen due to osteochondritis dissecans leading to lateral epicondylitis. The demand for available and anticipated treatment for tennis elbow has increased substantially in recent years, which is driving the growth of the global lateral epicondylitis market.

·         Some people think that majority of the tennis elbow injuries are related to tennis, but only 5% of lateral epicondylitis injuries are related to tennis. Around 10-15% of tennis players suffer from it at some point in their career.

·         In the U.S., over  30 million students participate in organized sports every year, with more than 3.5 million injuries reported.

·         According to National Safety Council (NSC) around 404,000 injuries were reported from basketball and 292,000 from football in 2019.

·         Age group of 5 years to 14 years accounted for almost 44% of total basketball injuries and 40% of lacrosse and rugby injuries.

·         This condition tends to affect men and women equally. Half of tennis players develop pain around the elbow, of which 75% represent true tennis elbow. It is more common in individuals older than 40 years of age.

·         In NFL, major league, and NBA, baseball pitchers are at a higher risk of sustaining elbow injury. Almost 40% of all injured athletes were baseball pitchers, with more than 20% of all sustained injuries treated via surgery.

·         Sachin Tendulkar suffered from a tennis elbow injury between 2004-2006. Tennis players like Andy Murray, Venus Williams, Juan Martin Del Potro, Aleksandra Wozniak, and NFL great Tom Brady, all have suffered from lateral epicondylitis in their respective careers.

All these injuries will lead to an increase in the number of diagnosis and treatment, which will directly contribute towards the growth of lateral epicondylitis market.

Technological advancement and favorable reimbursement

Technological advancements are one of the major reasons for the increasing global acceptance of lateral epicondylitis treatment methods. New treatment methods are painless and help patients recover quickly. Treatment methods will little to no incision are also being used to treat tennis elbow. Transcatheter arterial embolization (TAE) and Platelet-rich plasma (PRP) are innovative treatment methods for tennis elbow. TAE is an emerging treatment method that uses ultrasound to treat the affected part whereas PRP is a procedure that entails injecting the person’s platelets into the tendon to promote healing. Corticosteroid injections are another extensively used method of treatment for lateral epicondylitis. Short-term use of these injections poses very few side-effects but long-term use may have some serious consequences.

All these innovative methods heal the injury faster with little to no pain and contribute towards the increasing acceptance of the upcoming treatment methods, which in turn are fueling the growth of the lateral epicondylitis market.

Restraints

Sluggish Adoption Trend of New Effective Therapies

The low acceptance rate of new effective therapies is expected to restrict the growth of this market over the coming years. Though these methods are highly effective in treating the condition, the devices are highly expensive. Even if the patient does not opt for any kind of treatment, around 90% of people recover within one year. Since tennis elbow is a self-limiting condition, it gets healed by itself with complete rest. The injury has a recovery time of 6 months to 2 years depending upon the rest provided to the injured part. Most people tend to opt for resting instead of choosing treatment as it is very expensive. Private hospital tends to charge an exorbitant fee for the treatment, while only a few government hospitals have proper facilities to treat the condition. What’s more, patients often avoid seeking treatment considering the high treatment costs or inadequate treatment facilities, which is impeding the market growth for lateral epicondylitis market.

Global Lateral Epicondylitis (Tennis Elbow) Market: Treatment Type

Based on treatment type the global lateral epicondylitis market is segmented into corticosteroid injection, surgery, therapy, painkillers, NSAIDs, equipment, and other products. Surgery is often the last option for treating lateral epicondylitis. This segment includes treatments such as arthroscopy, open surgeries, and others. Additionally, deep tissue massage of the forearm is also an effective method to ease the pain and treat the injured arm. It enhances circulation and combines it with friction therapy to the tendons on the elbow joint to help it heal faster than just letting it rest. Additionally, Transcatheter arterial embolization (TAE) is an image-guided, non-surgical treatment method that reduces irregular blood flow around the affected area to ease the pain and reduce inflammation. Last but not least. corticosteroids injections, painkillers & NSAIDs are short-term solutions for the treatment and some of these may have side-effects as well.

Impact of COVID-19 in the industry

The onset of novel coronavirus has affected the global economy besides affecting business operations. Due to high infection rates and adverse impacts on public health systems, various countries had to enforce nationwide lockdowns, which significantly impacted the development of new treatment methods, medicines, and related services, as almost 90% of all clinical trials were either completely shut down or put on hold indefinitely. Industry players are currently considering digital diagnostic and treatment solutions to serve the community and provide newfangled opportunities to do business.

With the gloomy situation around the globe, major tournaments and competitions were canceled and are still being canceled. People were forced to stay indoors, resulting in a decrease in the number of diagnoses and medical treatments for lateral epicondylitis. As the focus on social-distancing grew, diagnosis, treatment, and surgeries were put on hold and people were forced to manage the condition at home with complete rest and over-the-counter medication.

 

Global Lateral Epicondylitis (Tennis Elbow): By End-User

The global market is segregated into hospital/clinic and pharmacy/drug stores. Tie-ups of government authorities with the hospitals for players’ safety and insurance are driving the growth of the hospital segment. Additionally, with the integration of the latest technology and treatment methods, hospitals nowadays prefer providing patients with percutaneous (smaller incision) surgery. When compared to open surgery with a wider incision, patients feel considerably less discomfort during percutaneous surgery conducted using radio wave frequency. Along with innovative treatment methods that are painless and facilitate faster healing, the aforementioned factors are driving the demand for lateral epicondylitis treatment. 


Source: BlueWeave Consulting

 

Global Lateral Epicondylitis (Tennis Elbow) Market: Regional Insights

The global lateral epicondylitis market is segmented into five regions: North America, Europe, the Asia-Pacific, Latin America, and the Middle East & Africa. North American market accounts for a significant share in the global lateral epicondylitis (tennis elbow) market.

American Football is one of the most popular sports in North America followed by baseball and tennis. The country also hosts the US Open--one of the four Grand Slam events. Tom Brady(NFL), Tiger Woods(Golf), Serena Williams(Tennis), Allen Iverson(Basketball) are some of the famous American athletes who suffered from tennis elbow in their careers. Almost 50% of all injuries sustained by the players in MLB (Major League Baseball) are arm injuries, as reported by Orthopedic Journal of Sports Medicine. High disposable income, well-established healthcare infrastructure, the strong financial position of hospitals, with the presence of leading global market players are driving the market growth for lateral epicondylitis in North America.

Europe and the Asia-Pacific is expected to grow significantly due to the emergence of various topical sprays, therapies, and injections that require little to no incision for the treatment of the condition. Latin America, along with the Middle East & Africa are also expected to show appreciable market growth in the forecast period.

Source: BlueWeave Consulting

Competitive landscape

The global lateral epicondylitis (tennis elbow) market is consolidated in nature. Some of the key players operating in the market include Stryker Corporation, Chugai Pharmaceutical Co., Ltd, Seikagaku Corporation, Teikoku Seiyaku Co., Ltd., DJO Global, Inc., Zimmer Biomet, Smith & Nephew plc, Pfizer Inc., 3M Company, Arthrex, and other prominent players. Mergers and acquisitions are some of the strategies adopted by the key manufacturers. New product launches, along with a strong focus on continuous technology innovations are also some strategies adopted by the major players. The companies are also trying to dominate the market by investing in research and development.

Various companies are striving to gain market share by adopting competitive strategies such as joint ventures and research partnerships. The market players compete based on product quality, conformance to standards and performance, and cost-effective manufacturing process, which in turn optimizes the process for better production.

Recent Development

·         November 2019, Prolotherapy injections and physiotherapy were used singly and in combination for lateral epicondylalgia: a single-blinded randomized clinical trial.

·         March 2019, New IR treatment for 'tennis elbow' was launched for reducing pain and inflammation without surgery.

·         Sep 2018, Platelet-Rich Plasma (PRP) was investigated for its effectiveness in speeding the healing of a variety of tendon injuries.

 

Scope of the Report

Attribute

Details

Years Considered

Historical data – 2017-2020

Base Year – 2021

Forecast – 2022 – 2027

Facts Covered

Revenue in USD Million

Market Coverage

U.S, Canada, Germany, UK, France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, Argentina, AUAE, South Africa, Saudi Arabia

Product/Service Segmentation

By Treatment Type, End-User, and Region

Key Players

Key players operating in the market include Stryker Corporation, Chugai Pharmaceutical Co., Ltd, Seikagaku Corporation, Teikoku Seiyaku Co., Ltd., DJO Global, Inc., Zimmer Biomet, Smith & Nephew plc, Pfizer Inc., 3M Company, Arthrex, and other prominent players.

 

Scope of the Report

 

By Treatment Type

Ø  Corticosteroid Injections

Ø  Surgery

Ø  Therapy (Shock Wave Therapy & Physical Therapy)

Ø  Painkillers and NSAIDS

Ø  Equipment's and Other Products

By End-User

Ø  Hospital/Clinic

Ø  Pharmacy/Drug Store 

By Region

Ø  North America

Ø  Europe

Ø  the Asia-Pacific (APAC)

Ø  Latin America (LATAM)

Ø  the Middle-East & Africa (MEA)

 

 

FAQs:

1.    What is the current size of the global lateral epicondylitis(tennis elbow) market?

Ans: Current size of the global lateral epicondylitis (tennis elbow) market is USD 9,159.73 million.

 

2.    What are the major factors driving the growth of the lateral epicondylitis market?

Ans: Increase in the number of injuries, innovation in technology & treatment type, innovative methods with little to no incision, government policies, and tie-ups with hospitals are some of the factors driving the market growth of lateral epicondylitis (tennis elbow) market.

 

3.    Who are the key players in the global lateral epicondylitis (tennis elbow) market?

Ans: Stryker Corporation, Chugai Pharmaceutical Co., Ltd, Seikagaku Corporation, Teikoku Seiyaku Co., Ltd., DJO Global, Inc., Zimmer Biomet, Smith & Nephew plc, Pfizer Inc., 3M Company, Arthrex, and others are some of the key players operating in the global lateral epicondylitis market.

 

4.    Which end-user segment accounted for the largest market share in the global lateral epicondylitis market?

Ans: Hospitals/clinics accounted for the larger market share in the global lateral epicondylitis market.

 

5.    Which region accounted for the largest market share in the global lateral epicondylitis market?

Ans: North America accounted for the largest market share in the global lateral epicondylitis market.